BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17300991)

  • 1. Oxcarbazepine improves mood in patients with epilepsy.
    Mazza M; Della Marca G; Di Nicola M; Martinotti G; Pozzi G; Janiri L; Bria P; Mazza S
    Epilepsy Behav; 2007 May; 10(3):397-401. PubMed ID: 17300991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
    Ettinger AB; Kustra RP; Hammer AE
    Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual functions in women with focal epilepsy: Relationship to demographic, clinical, hormonal and psychological variables.
    Hamed SA; Attiah FA; Gabra RH; Sherif TK
    Clin Neurol Neurosurg; 2020 Apr; 191():105697. PubMed ID: 32028129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
    Albani F; Baruzzi A;
    Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients.
    Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L
    Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
    Dogan EA; Usta BE; Bilgen R; Senol Y; Aktekin B
    Epilepsy Behav; 2008 Jul; 13(1):156-61. PubMed ID: 18331816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
    Harden CL; Lazar LM; Pick LH; Nikolov B; Goldstein MA; Carson D; Ravdin LD; Kocsis JH; Labar DR
    Epilepsia; 1999 Aug; 40(8):1129-34. PubMed ID: 10448827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
    Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term assessment of oxcarbazepine in a naturalistic setting: a retrospective study.
    Seneviratne U; D'Souza W; Cook M
    Acta Neurol Scand; 2008 May; 117(5):367-9. PubMed ID: 18028241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
    Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
    Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
    Pratoomsri W; Yatham LN; Sohn CH; Solomons K; Lam RW
    Bipolar Disord; 2005; 7 Suppl 5():37-42. PubMed ID: 16225559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.